Transcatheter Closure of Paravalvular Defects Using a Purpose-Specific Occluder
Fabian Nietlispach, MD,
Mark Johnson, MD,
Robert R. Moss, MBBS,
Namal Wijesinghe, MD,
Ronen Gurvitch, MBBS,
Edgar L.W. Tay, MBBS,
Christopher Thompson, MD,
John G. Webb, MD*
St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
* Reprint requests and correspondence: Dr. John G. Webb, St. Paul's Hospital, 1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada (Email: john.webb{at}vch.ca).
Objectives: This study sought to describe a method of paravalvular leak closure using a purpose-specific occlusion device.
Background: Transcatheter closure of paravalvular leaks has been hampered by technical challenges, the limitations of available imaging modalities, and the lack of closure devices specifically designed for this purpose.
Methods: Patients with severe symptomatic paravalvular regurgitation at high risk for repeat surgery underwent transcatheter leak closure. Both left ventricular puncture and retrograde transfemoral approaches were used with fluoroscopic and 3-dimensional transesophageal guidance. A purpose-specific occluder (Vascular Plug III, AGA Medical Corp., Plymouth, Minnesota) was used.
Results: Five patients with severe prosthetic mitral and aortic paravalvular leaks underwent attempted closure. Implantation of the device was successfully accomplished in all. In 1 patient, the plug interfered with closure of a mechanical valve leaflet and was removed and replaced with an alternate device. Complications included pericardial bleeding in 2 patients with a transapical approach. There was no procedural mortality. At a median follow-up of 191 days (interquartile range [IQR] 169 to 203 days) all patients were alive. New York Heart Association functional class fell from 4 (IQR 3 to 4) to 2 (IQR 2 to 3), hemoglobin rose from 89 g/l (IQR 87 to 108 g/l) to 115 g/l (IQR 104 to 118 g/l), creatinine fell from 109 µmol/l (IQR 106 to 132 µmol/l) to 89 µmol/l (IQR 89 to 126 µmol/l). Median echocardiographic follow-up at 58 days (IQR 56 to 70 days) reported residual regurgitation to be reduced from grade 4 to grade 2 (IQR 1.5 to 2.25).
Conclusions: Closure of mitral and aortic prosthetic paravalvular leaks with the Vascular Plug III using either a transapical (mitral) or a retrograde (aortic) approach appears promising.
Key Words: paravalvular regurgitation transapical Vascular Plug III hemolysis
|
Abbreviations and Acronyms
| | 3D = 3-dimensional | | IQR = interquartile range | | PVR = paravalvular regurgitation | | TEE = transesophageal echocardiography |
|
This article has been cited by other articles:

|
 |

|
 |
 
R. Gurvitch, A. Cheung, J. Ye, D. A. Wood, A. B. Willson, S. Toggweiler, R. Binder, and J. G. Webb
Transcatheter Valve-in-Valve Implantation for Failed Surgical Bioprosthetic Valves.
J. Am. Coll. Cardiol.,
November 15, 2011;
58(21):
2196 - 2209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Ruiz, V. Jelnin, I. Kronzon, Y. Dudiy, R. Del Valle-Fernandez, B. N. Einhorn, P. T. L. Chiam, C. Martinez, R. Eiros, G. Roubin, et al.
Clinical outcomes in patients undergoing percutaneous closure of periprosthetic paravalvular leaks.
J. Am. Coll. Cardiol.,
November 15, 2011;
58(21):
2210 - 2217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Sorajja, A. K. Cabalka, D. J. Hagler, and C. S. Rihal
Long-term follow-up of percutaneous repair of paravalvular prosthetic regurgitation.
J. Am. Coll. Cardiol.,
November 15, 2011;
58(21):
2218 - 2224.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|